Daniel Arber to Imatinib Mesylate
This is a "connection" page, showing publications Daniel Arber has written about Imatinib Mesylate.
Connection Strength
0.013
-
Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood. 2003 Jun 15; 101(12):4701-7.
Score: 0.013